Rossari Biotech Boosts Exports, Exits Low-Margin Businesses for Stronger Growth

• Rossari Biotech, a Mumbai-based chemical manufacturer, is focusing on exports, capacity utilization, and core chemical businesses for growth.
• Exports currently account for 27-28% of sales and are projected to reach 30% next fiscal year, reducing dependence on the domestic market.
• The company reported ₹582 crore revenue and ₹33 crore profit after tax in Q3FY26, with HPPC segment contributing 76-77% of revenues.
• Rossari Biotech plans to increase HPPC's share to 90% in five years, aiming to double sales and EBITDA, and has approved greenfield facilities in Saudi Arabia.
• To enhance profitability, the company will exit loss-making B2C and consumer cleaning businesses, focusing on higher-margin industrial and specialty chemicals.

Why It Matters: Rossari Biotech is strategically shifting towards higher-margin exports and core chemical segments for future growth.